Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Increases By 45.0%
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Increases By 45.0%
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 130,200 shares, an increase of 45.0% from the December 31st total of 89,800 shares. Based on an average daily volume of 101,000 shares, the short-interest ratio is currently 1.3 days.
全球 X 基因組學和生物技術 ETF（NASDAQ：GMNOM-獲得評級）是一月份短期利益大幅增加的接受者。截至 1 月 15 日，總共有 130,200 股的短期利息，較十二月三十一日共 89,800 股股份增加了 45.0%。根據每日平均成交量 101,000 股，短息比率目前為 1.3 天。
Hedge Funds Weigh In On Global X Genomics & Biotechnology ETF
對沖基金權衡全球 X 基因組學和生物技術 ETF
Hedge funds and other institutional investors have recently modified their holdings of the business. Simplex Trading LLC boosted its stake in shares of Global X Genomics & Biotechnology ETF by 198.6% during the third quarter. Simplex Trading LLC now owns 2,311 shares of the company's stock valued at $29,000 after purchasing an additional 1,537 shares in the last quarter. FORVIS Wealth Advisors LLC acquired a new stake in Global X Genomics & Biotechnology ETF in the third quarter valued at approximately $150,000. Avidian Wealth Solutions LLC boosted its stake in Global X Genomics & Biotechnology ETF by 6.8% in the second quarter. Avidian Wealth Solutions LLC now owns 12,302 shares of the company's stock valued at $150,000 after acquiring an additional 788 shares in the last quarter. Stelac Advisory Services LLC boosted its stake in Global X Genomics & Biotechnology ETF by 71.2% in the second quarter. Stelac Advisory Services LLC now owns 12,742 shares of the company's stock valued at $156,000 after acquiring an additional 5,301 shares in the last quarter. Finally, Beaumont Financial Advisors LLC acquired a new stake in Global X Genomics & Biotechnology ETF in the fourth quarter valued at approximately $166,000.
對沖基金和其他機構投資者最近修改了其業務的持有情況。在第三季度，單純交易有限責任公司將其在全球 X 基因組學和生物技術 ETF 的股份的股份權益提高了 198.6％。在上一季度額外購買 1,537 股股票後，單純交易有限責任公司現在擁有該公司 2,311 股股票，價值為 29,000 美元。福維斯財富顧問有限責任公司在第三季度收購了全球 X 基因組學和生物技術 ETF 的新股份，價值約為 15 萬美元。Avidian 財富管理有限責任公司於第二季度將其在全球 X 基因組學及生物技術 ETF 的股份提升 6.8%。艾維迪財富管理有限責任公司現在擁有該公司 12,302 股股票，價值為 15 萬美元，在上一季度額外收購 788 股後，該公司股票的價值為 15 萬美元。Stelac 諮詢服務有限責任公司在第二季度將其在全球 X 基因組學和生物技術 ETF 的股份提高了 71.2％。Stelac 諮詢服務有限責任公司現在擁有該公司 12,742 股價值為 156,000 美元的股票，在上個季度額外收購 5,301 股之後。最後，博蒙特理財顧問有限責任公司在第四季度收購了全球 X 基因組學和生物技術 ETF 的新股份，價值約為 166,000 美元。
Global X Genomics & Biotechnology ETF Price Performance
全球 X 基因組學及生物科技 ETF 價格表現
Shares of NASDAQ GNOM traded up $0.12 during midday trading on Friday, reaching $13.83. 64,314 shares of the company's stock traded hands, compared to its average volume of 69,001. The stock's 50 day simple moving average is $13.08 and its 200-day simple moving average is $13.45. Global X Genomics & Biotechnology ETF has a one year low of $10.48 and a one year high of $17.02.
納斯達克股票在周五中間交易期間上漲了 0.12 美元，達到 13.83 美元。與其平均成交量為 69,001 相比，該公司股票交易手中的 64,314 股。該股票的 50 天簡單移動平均線為 13.08 美元，其 200 天的簡單移動平均線為 13.45 美元。全球 X 基因組學與生物科技 ETF 擁有一年低點 10.48 美元，一年新高為 17.02 美元。
Global X Genomics & Biotechnology ETF Company Profile
全球 X 基因組學及生物科技 ETF 公司簡介
Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.
Complete Genomics, Inc 是一家生命科學公司，已開發並將脫氧核糖核酸（DNA）測序平台商業化。其完整的基因體分析平台 (CGA) 平台結合其人類基因組測序技術、先進的資訊學和資料管理軟體及其端對端的外包服務模式，為客戶提供可用於基因組研究的資料。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Global X Genomics & Biotechnology ETF (GNOM)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 免費獲取有關全球 X 基因組學及生物科技 ETF（GNOM）的研究報告
- 市場節拍週的回顧 — 1/23-1/27
- 為什麼清醒在一天內飆升近 100％
- 乘坐這些鐵路股票以獲得增長和收入
- ASML 今年看到籌碼需求上升，提高了銷售觀點
- KLA 公司：陷入困境的半市場中的實力
Receive News & Ratings for Global X Genomics & Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收全球 X 基因組學及生物科技 ETF 的最新消息和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關 Global X 基因組學和生物技術 ETF 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。